Congenital Neutropenia Treatment Market - Global Outlook and Forecast 2021-2027

April 2021 | 93 pages | ID: C11E2E8DB415EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Congenital Neutropenia Treatment in Global, including the following market information:

Global Congenital Neutropenia Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Congenital Neutropenia Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Congenital Neutropenia Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Congenital Neutropenia Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Congenital Neutropenia Treatment Market Segment Percentages, By Type, 2020 (%)

• By Treatment Type
• Antibiotic Therapy
• Colony-Stimulating Factor Therapy
• Granulocyte Transfusion
• Splenectomy Procedure
• Others
• By Type
• Idiopathic
• Cyclic
• Autoimmune
• By Route of Administration
• Oral
• Parenteral
• Others

China Congenital Neutropenia Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Congenital Neutropenia Treatment Market Segment Percentages, By Application, 2020 (%)

• Hospitals
• Specialty Clinics
• Others

Global Congenital Neutropenia Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Congenital Neutropenia Treatment Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Congenital Neutropenia Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Congenital Neutropenia Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Amgen
• Spectrum Pharmaceuticals
• Generon
• BeyondSpring Pharmaceuticals
• Myelo Therapeutics
• Cellerant Therapeutics
• Norvatis(Sandoz)

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Inhalation Sedatives Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Inhalation Sedatives Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL INHALATION SEDATIVES OVERALL MARKET SIZE

2.1 Global Inhalation Sedatives Market Size: 2021 VS 2027
2.2 Global Inhalation Sedatives Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Inhalation Sedatives Players in Global Market
3.2 Top Global Inhalation Sedatives Companies Ranked by Revenue
3.3 Global Inhalation Sedatives Revenue by Companies
3.4 Top 3 and Top 5 Inhalation Sedatives Companies in Global Market, by Revenue in 2020
3.5 Global Companies Inhalation Sedatives Product Type
3.6 Tier 1, Tier 2 and Tier 3 Inhalation Sedatives Players in Global Market
  3.6.1 List of Global Tier 1 Inhalation Sedatives Companies
  3.6.2 List of Global Tier 2 and Tier 3 Inhalation Sedatives Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Inhalation Sedatives Market Size Markets, 2021 & 2027
  4.1.2 Sevoflurane
  4.1.3 Desflurane
  4.1.4 Isoflurane
  4.1.5 Nitrous Oxide
4.2 By Type - Global Inhalation Sedatives Revenue & Forecasts
  4.2.1 By Type - Global Inhalation Sedatives Revenue, 2016-2021
  4.2.2 By Type - Global Inhalation Sedatives Revenue, 2022-2027
  4.2.3 By Type - Global Inhalation Sedatives Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Inhalation Sedatives Market Size, 2021 & 2027
  5.1.2 Hospitals
  5.1.3 Ambulatory Surgical Centers
  5.1.4 Others
5.2 By Application - Global Inhalation Sedatives Revenue & Forecasts
  5.2.1 By Application - Global Inhalation Sedatives Revenue, 2016-2021
  5.2.2 By Application - Global Inhalation Sedatives Revenue, 2022-2027
  5.2.3 By Application - Global Inhalation Sedatives Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Inhalation Sedatives Market Size, 2021 & 2027
6.2 By Region - Global Inhalation Sedatives Revenue & Forecasts
  6.2.1 By Region - Global Inhalation Sedatives Revenue, 2016-2021
  6.2.2 By Region - Global Inhalation Sedatives Revenue, 2022-2027
  6.2.3 By Region - Global Inhalation Sedatives Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Inhalation Sedatives Revenue, 2016-2027
  6.3.2 US Inhalation Sedatives Market Size, 2016-2027
  6.3.3 Canada Inhalation Sedatives Market Size, 2016-2027
  6.3.4 Mexico Inhalation Sedatives Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Inhalation Sedatives Revenue, 2016-2027
  6.4.2 Germany Inhalation Sedatives Market Size, 2016-2027
  6.4.3 France Inhalation Sedatives Market Size, 2016-2027
  6.4.4 U.K. Inhalation Sedatives Market Size, 2016-2027
  6.4.5 Italy Inhalation Sedatives Market Size, 2016-2027
  6.4.6 Russia Inhalation Sedatives Market Size, 2016-2027
  6.4.7 Nordic Countries Inhalation Sedatives Market Size, 2016-2027
  6.4.8 Benelux Inhalation Sedatives Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Inhalation Sedatives Revenue, 2016-2027
  6.5.2 China Inhalation Sedatives Market Size, 2016-2027
  6.5.3 Japan Inhalation Sedatives Market Size, 2016-2027
  6.5.4 South Korea Inhalation Sedatives Market Size, 2016-2027
  6.5.5 Southeast Asia Inhalation Sedatives Market Size, 2016-2027
  6.5.6 India Inhalation Sedatives Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Inhalation Sedatives Revenue, 2016-2027
  6.6.2 Brazil Inhalation Sedatives Market Size, 2016-2027
  6.6.3 Argentina Inhalation Sedatives Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Inhalation Sedatives Revenue, 2016-2027
  6.7.2 Turkey Inhalation Sedatives Market Size, 2016-2027
  6.7.3 Israel Inhalation Sedatives Market Size, 2016-2027
  6.7.4 Saudi Arabia Inhalation Sedatives Market Size, 2016-2027
  6.7.5 UAE Inhalation Sedatives Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 AbbVie Inc
  7.1.1 AbbVie Inc Corporate Summary
  7.1.2 AbbVie Inc Business Overview
  7.1.3 AbbVie Inc Inhalation Sedatives Major Product Offerings
  7.1.4 AbbVie Inc Inhalation Sedatives Revenue in Global (2016-2021)
  7.1.5 AbbVie Inc Key News
7.2 Baxter International Inc
  7.2.1 Baxter International Inc Corporate Summary
  7.2.2 Baxter International Inc Business Overview
  7.2.3 Baxter International Inc Inhalation Sedatives Major Product Offerings
  7.2.4 Baxter International Inc Inhalation Sedatives Revenue in Global (2016-2021)
  7.2.5 Baxter International Inc Key News
7.3 Novatis(Sandoz)
  7.3.1 Novatis(Sandoz) Corporate Summary
  7.3.2 Novatis(Sandoz) Business Overview
  7.3.3 Novatis(Sandoz) Inhalation Sedatives Major Product Offerings
  7.3.4 Novatis(Sandoz) Inhalation Sedatives Revenue in Global (2016-2021)
  7.3.5 Novatis(Sandoz) Key News
7.4 Fresenius
  7.4.1 Fresenius Corporate Summary
  7.4.2 Fresenius Business Overview
  7.4.3 Fresenius Inhalation Sedatives Major Product Offerings
  7.4.4 Fresenius Inhalation Sedatives Revenue in Global (2016-2021)
  7.4.5 Fresenius Key News
7.5 Halocarbon
  7.5.1 Halocarbon Corporate Summary
  7.5.2 Halocarbon Business Overview
  7.5.3 Halocarbon Inhalation Sedatives Major Product Offerings
  7.5.4 Halocarbon Inhalation Sedatives Revenue in Global (2016-2021)
  7.5.5 Halocarbon Key News
7.6 Hikma Pharmaceuticals PLC
  7.6.1 Hikma Pharmaceuticals PLC Corporate Summary
  7.6.2 Hikma Pharmaceuticals PLC Business Overview
  7.6.3 Hikma Pharmaceuticals PLC Inhalation Sedatives Major Product Offerings
  7.6.4 Hikma Pharmaceuticals PLC Inhalation Sedatives Revenue in Global (2016-2021)
  7.6.5 Hikma Pharmaceuticals PLC Key News
7.7 Piramal Enterprises Ltd
  7.7.1 Piramal Enterprises Ltd Corporate Summary
  7.7.2 Piramal Enterprises Ltd Business Overview
  7.7.3 Piramal Enterprises Ltd Inhalation Sedatives Major Product Offerings
  7.4.4 Piramal Enterprises Ltd Inhalation Sedatives Revenue in Global (2016-2021)
  7.7.5 Piramal Enterprises Ltd Key News
7.8 Troikaa Pharmaceuticals Ltd
  7.8.1 Troikaa Pharmaceuticals Ltd Corporate Summary
  7.8.2 Troikaa Pharmaceuticals Ltd Business Overview
  7.8.3 Troikaa Pharmaceuticals Ltd Inhalation Sedatives Major Product Offerings
  7.8.4 Troikaa Pharmaceuticals Ltd Inhalation Sedatives Revenue in Global (2016-2021)
  7.8.5 Troikaa Pharmaceuticals Ltd Key News
7.9 Jiangsu Hengrui Medicine Co.,Ltd
  7.9.1 Jiangsu Hengrui Medicine Co.,Ltd Corporate Summary
  7.9.2 Jiangsu Hengrui Medicine Co.,Ltd Business Overview
  7.9.3 Jiangsu Hengrui Medicine Co.,Ltd Inhalation Sedatives Major Product Offerings
  7.9.4 Jiangsu Hengrui Medicine Co.,Ltd Inhalation Sedatives Revenue in Global (2016-2021)
  7.9.5 Jiangsu Hengrui Medicine Co.,Ltd Key News
7.10 Lunan Pharmaceutical Group Co.,Ltd
  7.10.1 Lunan Pharmaceutical Group Co.,Ltd Corporate Summary
  7.10.2 Lunan Pharmaceutical Group Co.,Ltd Business Overview
  7.10.3 Lunan Pharmaceutical Group Co.,Ltd Inhalation Sedatives Major Product Offerings
  7.10.4 Lunan Pharmaceutical Group Co.,Ltd Inhalation Sedatives Revenue in Global (2016-2021)
  7.10.5 Lunan Pharmaceutical Group Co.,Ltd Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Congenital Neutropenia Treatment Market Opportunities & Trends in Global Market
Table 2. Congenital Neutropenia Treatment Market Drivers in Global Market
Table 3. Congenital Neutropenia Treatment Market Restraints in Global Market
Table 4. Key Players of Congenital Neutropenia Treatment in Global Market
Table 5. Top Congenital Neutropenia Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Congenital Neutropenia Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Congenital Neutropenia Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Congenital Neutropenia Treatment Product Type
Table 9. List of Global Tier 1 Congenital Neutropenia Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Congenital Neutropenia Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Congenital Neutropenia Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Congenital Neutropenia Treatment Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Congenital Neutropenia Treatment Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Congenital Neutropenia Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Congenital Neutropenia Treatment Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Congenital Neutropenia Treatment Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Congenital Neutropenia Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Congenital Neutropenia Treatment Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Congenital Neutropenia Treatment Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Congenital Neutropenia Treatment Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Congenital Neutropenia Treatment Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Congenital Neutropenia Treatment Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Congenital Neutropenia Treatment Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Congenital Neutropenia Treatment Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Congenital Neutropenia Treatment Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Congenital Neutropenia Treatment Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Congenital Neutropenia Treatment Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Congenital Neutropenia Treatment Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Congenital Neutropenia Treatment Revenue, (US$, Mn), 2022-2027
Table 30. Amgen Corporate Summary
Table 31. Amgen Congenital Neutropenia Treatment Product Offerings
Table 32. Amgen Congenital Neutropenia Treatment Revenue (US$, Mn), (2016-2021)
Table 33. Spectrum Pharmaceuticals Corporate Summary
Table 34. Spectrum Pharmaceuticals Congenital Neutropenia Treatment Product Offerings
Table 35. Spectrum Pharmaceuticals Congenital Neutropenia Treatment Revenue (US$, Mn), (2016-2021)
Table 36. Generon Corporate Summary
Table 37. Generon Congenital Neutropenia Treatment Product Offerings
Table 38. Generon Congenital Neutropenia Treatment Revenue (US$, Mn), (2016-2021)
Table 39. BeyondSpring Pharmaceuticals Corporate Summary
Table 40. BeyondSpring Pharmaceuticals Congenital Neutropenia Treatment Product Offerings
Table 41. BeyondSpring Pharmaceuticals Congenital Neutropenia Treatment Revenue (US$, Mn), (2016-2021)
Table 42. Myelo Therapeutics Corporate Summary
Table 43. Myelo Therapeutics Congenital Neutropenia Treatment Product Offerings
Table 44. Myelo Therapeutics Congenital Neutropenia Treatment Revenue (US$, Mn), (2016-2021)
Table 45. Cellerant Therapeutics Corporate Summary
Table 46. Cellerant Therapeutics Congenital Neutropenia Treatment Product Offerings
Table 47. Cellerant Therapeutics Congenital Neutropenia Treatment Revenue (US$, Mn), (2016-2021)
Table 48. Norvatis(Sandoz) Corporate Summary
Table 49. Norvatis(Sandoz) Congenital Neutropenia Treatment Product Offerings
Table 50. Norvatis(Sandoz) Congenital Neutropenia Treatment Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Congenital Neutropenia Treatment Segment by Type
Figure 2. Congenital Neutropenia Treatment Segment by Application
Figure 3. Global Congenital Neutropenia Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Congenital Neutropenia Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Congenital Neutropenia Treatment Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Congenital Neutropenia Treatment Revenue in 2020
Figure 8. By Type - Global Congenital Neutropenia Treatment Revenue Market Share, 2016-2027
Figure 9. By Application - Global Congenital Neutropenia Treatment Revenue Market Share, 2016-2027
Figure 10. By Region - Global Congenital Neutropenia Treatment Revenue Market Share, 2016-2027
Figure 11. By Country - North America Congenital Neutropenia Treatment Revenue Market Share, 2016-2027
Figure 12. US Congenital Neutropenia Treatment Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Congenital Neutropenia Treatment Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Congenital Neutropenia Treatment Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Congenital Neutropenia Treatment Revenue Market Share, 2016-2027
Figure 16. Germany Congenital Neutropenia Treatment Revenue, (US$, Mn), 2016-2027
Figure 17. France Congenital Neutropenia Treatment Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Congenital Neutropenia Treatment Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Congenital Neutropenia Treatment Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Congenital Neutropenia Treatment Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Congenital Neutropenia Treatment Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Congenital Neutropenia Treatment Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Congenital Neutropenia Treatment Revenue Market Share, 2016-2027
Figure 24. China Congenital Neutropenia Treatment Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Congenital Neutropenia Treatment Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Congenital Neutropenia Treatment Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Congenital Neutropenia Treatment Revenue, (US$, Mn), 2016-2027
Figure 28. India Congenital Neutropenia Treatment Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Congenital Neutropenia Treatment Revenue Market Share, 2016-2027
Figure 30. Brazil Congenital Neutropenia Treatment Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Congenital Neutropenia Treatment Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Congenital Neutropenia Treatment Revenue Market Share, 2016-2027
Figure 33. Turkey Congenital Neutropenia Treatment Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Congenital Neutropenia Treatment Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Congenital Neutropenia Treatment Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Congenital Neutropenia Treatment Revenue, (US$, Mn), 2016-2027
Figure 37. Amgen Congenital Neutropenia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Spectrum Pharmaceuticals Congenital Neutropenia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Generon Congenital Neutropenia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. BeyondSpring Pharmaceuticals Congenital Neutropenia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Myelo Therapeutics Congenital Neutropenia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Cellerant Therapeutics Congenital Neutropenia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)